SCYNEXIS

SCYNEXIS FCF CAGR 5Y

The FCF CAGR (5 Year) of SCYNEXIS (SCYX) as of Oct 20, 2026 is -36.04 %.

FCF CAGR 5Y

-36.04 %

Last updated:

FCF CAGR (5 Year) of SCYNEXIS is 2025 -36.04 % . FCF CAGR (5 Year) of SCYNEXIS was 2024 - . It decreases by % lower compared to the previous year.

The SCYNEXIS FCF CAGR 5Y history

The SCYNEXIS FCF CAGR 5Y history
YEARFCF CAGR 5YYoY
-36.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

FCF CAGR (5 Year) of SCYNEXIS is -36.04 % in 2025.

On Eulerpool you can find the complete historical development of FCF CAGR (5 Year) SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

The 5-year FCF CAGR shows the compound annual growth rate of free cash flow over five years.

To evaluate FCF CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF CAGR (5 Year).

FCF CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track FCF CAGR (5 Year)'s SCYNEXIS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — SCYNEXIS

All Key Metrics — SCYNEXIS